Clinical trial
Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
NCT03476330 is registered in ClinicalTrials.gov with Children's Hospital Medical Center, Cincinnati as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Quercetin Chemoprevention for Squamous Cell Carcinoma in Patients With Fanconi Anemia
- Lead sponsor
- Children's Hospital Medical Center, Cincinnati
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 8, 2018
- Completion date
- January 9, 2026
- Enrollment
- 48 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fanconi anemia, squamous cell carcinoma